Patents by Inventor Mami TAKASAKI

Mami TAKASAKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240035000
    Abstract: This invention is intended to suppress cell death occurring at the time of transition of adherent culture of pluripotent stem cells to suspension culture thereof. Pluripotent stem cells are subjected to adherent culture in a liquid medium comprising a PKC? inhibitor and a TNKS inhibitor and then to suspension culture.
    Type: Application
    Filed: December 7, 2021
    Publication date: February 1, 2024
    Applicants: KANEKA CORPORATION, RIKEN
    Inventors: Sho KAMBAYASHI, Yohei HAYASHI, Mami TAKASAKI
  • Publication number: 20230094568
    Abstract: Pluripotent stem cells are suspension-cultured with the undifferentiated state thereof maintained. In suspension culture of pluripotent stem cells, the undifferentiated state is maintained by the presence of a PKC inhibitor, especially, a PKC? inhibitor, and a tankyrase inhibitor (TNKS inhibitor).
    Type: Application
    Filed: February 12, 2021
    Publication date: March 30, 2023
    Applicants: KANEKA CORPORATION, RIKEN
    Inventors: Kazuhiro TAKEUCHI, Masato IBUKI, Yohei HAYASHI, Mami TAKASAKI, Sho KAMBAYASHI, Yoshikazu KAWAI